Airway clearance techniques in cystic fibrosis: Physiology, devices and the future

Journal of the Royal Society of Medicine, Supplement

Volumn 100, Issue 47, 2007, Pages 3-23

  Kendrick, Adrian H ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHIECTASIS; CONFERENCE PAPER; COUGHING; CYSTIC FIBROSIS; FUNCTIONAL RESIDUAL CAPACITY; HUMAN; LUNG CLEARANCE; LUNG PRESSURE; MATHEMATICAL MODEL; MUCUS SECRETION; PEAK EXPIRATORY FLOW; RESPIRATORY AIRFLOW;

CYSTIC FIBROSIS; EQUIPMENT DESIGN; FORCED EXPIRATORY FLOW RATES; HUMANS; LUNG; MODELS, THEORETICAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATION, ARTIFICIAL;

EID: 34548128037     PISSN: 02675331     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (132)

1. Yankaskas JR, Marshall BC, Sufian B, Simon RH, Rodman D. Cystic fibrosis adult care: Consensus conference report. Chest 2004;125:1-39
2. Ranga V, Kleinerman J. Structure and function of small airways in health and disease. Arch Pathol Lab Med 1978;102:609-17
3. Kulaksiz H, Schmid A, Honschied M, Ramaswamy A, Cetin Y. Clara cells impact in air-side activation of CFTR in small airways. Proc Natl Acad Sci USA 2002;99:6796-801
4. Engelhardt JF, Zepada M, Cohn JA, Yankaskas JR, Wilson JM. Expression of cystic fibrosis gene in adult human lung. J Clin Invest 1994;2:737-49
5. Weibel ER. The Pathway of Oxygen. Cambridge, Mass: Harvard University Press, 1984
6. Desplechain C, Foliguet B, Barrat E, Grignon G, Touati F. The pores of Kohn in pulmonary alveoli. Bull Eur Physiopathol Respir 1983;19:59-68
7. Macklem PT. Airway obstruction and collateral ventilation. Physiol Rev 1971;51:368-436
8. Hogg JC, Macklem PT, Thurlbeck WM. The resistance of collateral channels in excised human lungs. J Clin Invest 1969;48:421-31
9. Milic-Emili J. Work of breathing. In: Crystal RG, West JB, eds. The Lung: Scientific Foundations. New York: Raven, 1991:1065-75
10. Campbell EJM, Westlake EK, Cherniack RM. Simple methods of estimating oxygen consumption and the efficiency of the muscles of breathing. J Appl Physiol 1957;11:303-8
11. Schroder J-M, Harder J. Human beta-defensin-2. Int J Biochem Cell Biol 1999;31:645-51
12. Laube DM, Yim S, Ryan LK, Kisich KO, Diamond G. Antimicrobial peptides in the airway. Curr Top Microbiol Immunol 2006;306:153-82
13. Wanner A, Salathé M, O'Riordan TG. Mucociliary clearance in the airways. Am J Respir Crit Care Med 1996;154:1868-902
14. Houtmeyers E, Gosselink R, Gayan-Ramirez G, Decramer M. Regulation of mucociliary clearance in health and disease. Eur Respir J 1999;13:1177-88
15. Leith DE. Cough. In: Brain JD, Proctor DF, R'ilid LM, eds. Respiratory Defence Mechanisms: Part II. New York: Marcel Dekker, 1977
16. Ross BB, Gramiak R, Rahn H. Physical dynamics of the cough mechanism. J Appl Physiol 1955;8:264-8
17. Bennett WD, Foster WM, Chapman WF. Cough-enhanced mucus clearance in the normal lung. J Appl Physiol 1990;69:1670-5
18. Bennett, WD, Zeman KL. Effect of enhanced supra-maximal flows on cough clearance. J Appl Physiol 1994;77:1577-1583
19. Knudson RJ, Mead J, Knudson DE. Contribution of airway collapse to supramaximal expiratory flows. J Appl Physiol 1974;36:653-67
20. Von Leden H, Isshiki N. An analysis of cough at the level of the larynx. Arch Otolaryngol 1965;81:616-25
21. Clarke S, Jones JG, Oliver DR. Resistance to two-phase gas-liquid flow in airways. J Appl Physiol 1970;29:464-71
22. Scherer PW. Mucus transport by cough. Chest 1981;805:830-3
23. King M, Brock G, Lundell C. Clearance of mucus by simulated cough. J Appl Physiol 1985;58:1776-85
24. Kim CS, Brown LK, Lewars GG, Sackner MA. Deposition of aerosol particles and flow resistance in mathematical and experimental airway models. J Appl Physiol 1983;55:154-63
25. McCool FD, Leith DE. Pathophysiology of cough. Clin Chest Med 1987; 2:189-95
26. Albers GM, Tomkiewicz RP, May MK, Ramirez OE, Rubin BK. Ring distraction technique for measuring surface tension of sputum: relationship to sputum clearability. J Appl Physiol 1996;81:2690-5
27. King M. The role of mucus viscoelasticity in cough clearance. Biorheology 1987;24: 89-97
28. King M, Zahm JM, Pierrot D, Vaquez-Girod S, Puchelle E. The role of mucus gel viscosity spinnability and adhesive properties in clearance by simulated cough. Biorheology 1989;26:747-52
29. King M, Zidulka A, Phillips DM, Wight D, Gross D, Chang HK. Tracheal mucus clearance in high-frequency oscillation: effect of peak flow rate bias. Eur Respir J 1990;3:6-13
30. Harris RS, Lawson TV The relative mechanical effectiveness and efficiency of successive voluntary coughs in healthy young adults. Clin Sci 1968;34:569
31. Rogers DF, Mucus hypersecretion in chronic obstructive pulmonary disease. In: Chronic Obstructive Pulmonary Disease: Pathogenesis to Treatment. Novartis Foundation Symposium 234. New York: John Wiley, 2001
32. Annesi I, Kauffmann F. Is respiratory mucus hypersecretion really an innocent disorder? A 22-year mortality survey of 1,061 working men. Am Rev Respir Dis 1986;134:688-93
33. Lange P, Nyboe J, Appleyard M, Jensen G, Schnohr P. Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes. Thorax 1990;45:579- 85
34. 1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med 1996; 153: 1530-5
35. Zapatal A, Motoyama EK, Gibson LE, Bouhuys A. Pulmonary-mechanics in asthma and cystic fibrosis. Pediatrics 1971;48:64-72
36. Lamarre A, Reilly BJ, Bryan AC, Levison H. Early detection of pulmonary function abnormalities in cystic fibrosis. Pediatrics 1972;50: 291-8
37. Reis AL, Sosa G, Prewitt L, Friedman PJ, Harwood IR. Restricted pulmonary function in cystic fibrosis. Chest 1988;94:575-9
38. Mansell A, Dubrawsky C, Levison H, Bryan AC, Crozier DN. Lung elastic recoil in cystic fibrosis. Am Rev Respir Dis 1974;109:190-7
39. Mier A, Ridington A, Brophy C, Hudson M, Green M. Respiratory muscle function in cystic fibrosis. Thorax 1990;45:750-2
40. Smith JA, Owen EC, Jones AM, Dodd ME, Webb AK, Woodcock A. Objective measurement of cough during pulmonary exacerbations in adults with cystic fibrosis. Thorax 2006;61:425-9
41. Lands LC, Heigenhauser GJF, Jones NL. Analysis of factors limiting maximal exercise performance in advanced cystic fibrosis. Clin Sci 1992;83:391-7
42. Tiddens HAWM, Koopman LP, et al. Cartilaginous airway wall dimensions and airway resistance in cystic fibrosis. Eur Resp J 2000;15: 735-42
43. Soboya RE, Tausig LM. Quantitative aspects of lung pathology in cystic fibrosis. Am Rev Respir Dis 1986;134:290-5
44. Bell SC, Saunders MJ, Elborn JS, Shale DJ. Resting energy expenditure and oxygen cost of breathing in patients with cystic fibrosis. Thorax 1996;51:126-31
45. Rosenstein BJ, Zeitlin PL. Cystic Fibrosis. Lancet 1998; 351: 277-82
46. Goldman MJ, Anderson GM, Stolzenberg ED, Kari UP, Zasloff M, Wilson J. Human b-defensin-1 is a salt-sensitive antibiotic in the lung that is inactivated in cystic fibrosis. Cell 1997;88:553-60
47. Bilton D, Mahadeva R. New treatments in adult cystic fibrosis. J R Soc Med 1997;90(Suppl 31):2-5
48. Regnis JA, Robinson M, Bailey DL, et al. Mucociliary clearance in patients with cystic fibrosis and in normal subjects. Am J Respir Crit Care Med 1994;150:66-71
49. Matthys H, Kohler D. Bronchial clearance in cystic fibrosis. Eur J Respir Dis 1986;146:311-18
50. Yeates DB, Sturgess JM, Kahn SR, Levison H, Aspin N. Mucociliary transport in trachea of patients with cystic fibrosis. Arch Dis Child 1976; 51:28-33
51. Wood RE, Wanner A, Hirsch J, Di Sant'Agnese A. Tracheal mucociliary transport in patients with cystic fibrosis and its stimulation by terbutaline. Am Rev Respir Dis 1975;111:733-8
52. AARC Clinical Practice Guideline. Directed cough, use of positive airway pressure adjuncts to bronchial hygiene therapy. Respir Care 1993;38:495-521
53. Association of Chartered Physiotherapists in Cystic Fibrosis. Clinical Guidelines for the Physiotherapy Management of Cystic Fibrosis. Kent: Cystic Fibrosis Trust, 2003
54. Hess DR. The evidence for secretion clearance techniques. Respir Care 2001;46:1276-93
55. Kim CS, Rodriguez CR, Eldridge MA, Sackner MA. Criteria for mucus transport in the airways by two-phase gas-liquid flow mechanism. J Appl Physiol 1986;60:901-7
56. Kim CS, Greene MA, Sankaran S, Sackner MA. Mucus transport in the airways by two-phase gas-liquid flow mechanism: continuous flow model. J Appl Physiol 1986;60:908-17
57. Kim CS, Iglesias AJ, Sackner MA. Mucus clearance by two-phase gas-liquid flow mechanism: asymmetric periodic flow model. J Appl Physiol 1987;62:959-71
58. Gross D, Zidulka A, O'Brien C, et al. Peripheral mucociliary clearance with high-frequency chest wall compression. J Appl Physiol 1985;58: 1157-63
59. App EA, Kieselmann R, Reinhardt D, et al. Sputum rheology changes in cystic fibrosis lung disease following two different types of physiotherapy. Chest 1998;114:171-7
60. Hasani A, Pavia D, Agnew JE, Clarke SW. Regional lung clearance during cough and forced expiration technique (FET): effects of flow and visco-elasticity. Thorax 1994;49:557-61
61. Konstan MW, Stern RC, Doershuk CF. Efficacy of the Flutter device for airway mucus clearance in patients with cystic fibrosis. J Pediatr 1994;124:689-93
62. Arora NS, Gal TJ. Cough dynamics during progressive expiratory muscle weakness in healthy curanized subjects. J Appl Physiol 1981;51:494-8
63. van der Schans CP. Forced expiratory manoeuvres to increase transport of the bronchial mucus: a mechanistic approach. Monaldi Arch Chest Dis 1997;52:367-70
64. McCarren B, Alison JA, Herbert RD. Vibration and its effect on the respiratory system. Aust J Physiother 2006;52:39-43
65. McCarren B, Alison JA, Herbert RD. Manual vibration increases expiratory flow rate via increased intrapleural pressure in healthy adults: and experimental study. Aust J Physiother 2006;52:267-71
66. McCarren B, Alison JA. Physiological effects of vibration in subjects with cystic fibrosis. Eur Respir J 2006;27:1204-9
67. Fink JB. Positive pressure techniques for airway clearance. Respir Care 2002;47:786-96
68. Delaunois L. Anatomy and physiology of collateral respiratory airways. Eur Respir J 1989;2:893-904
69. Volsko TA, DiFiore JM, Chatburn RL. Performance comparison of two oscillating positive expiratory pressure devices: Acapella versus Flutter. Respir Care 2003;48:124-30
70. van der Schans C, Prasad A, Main E. Chest physiotherapy compared to no chest physiotherapy for cystic fibrosis. In: The Cochrane Library, Issue 2. Chichester: Wiley, 2000
71. Main E, Prasad A, van der Schans C. Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis. In: The Cochrane Library, Issue 1. Chichester: Wiley, 2005
72. Elkins MR, Jones A, van der Schans C. Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis. In: The Cochrane Library, Issue 1. Chichester: Wiley, 2004
73. Moran F, Bradley J. Non-invasive ventilation for cystic fibrosis. In: The Cochrane Library, Issue 2. Chichester: Wiley, 2003
74. Bradley JM, Moran FM, Elborn JS. Evidence for physical therapies (airway clearance and physical training) in cystic fibrosis. An overview of five Cochrane systematic reviews. Respir Med 2006;100:191-201
75. McCool FD, Rosen MJ. Non-pharmacologic airway clearance therapies: ACCP evidence-based clinical practical guidelines. Chest 2006;129:250S- 9
76. Braggion C, Cappelletti LM, Cornacchia M, Zanolla L, Mastella G. Short-term effects of three chest physiotherapy regimens in patients hospitalized for pulmonary exacerbations of cystic fibrosis: a cross-over randomized study. Pediatr Pulmonol 1995;19:16-22
77. Pfleger A, Theissl B, Oberwaldner B, Zach MS. Self-administered physiotherapy in cystic fibrosis: a comparative study of high-pressure PEP and autogenic drainage. Lung 1992;170:323-30
78. Rossman CM, Waldes R, Sampson D, Newhouse MT. Effect of chest physiotherapy on the removal of mucus in patients with cystic fibrosis. Am Rev Respir Dis 1982;126:131-5
79. van der Schans CP, van der Mark TW, de Vreies G, et al. Effect of positive expiratory pressure breathing in patients with cystic fibrosis. Thorax 1991; 46: 252-6
80. Mortensen J, Falk M, Groth S, Jensen C. The effects of postural drainage and positive expiratory pressure physiotherapy on tracheobronchial clearance in cystic fibrosis. Chest 1991;100:1350-7
81. Falk M, Mortensen J, Kelstrup M, Laning S, Larsen L, Ulrik CS. Short-term effects of positive expiratory pressure and the forced expiration technique on mucus clearance and lung function in CF [Abstract]. Pediatr Pulmonol 1993;(Suppl 9):241
82. Darbee J, Dadparvar S, Bensel K, Jehan A, Watkins M, Holsclaw D. Radio-nucleotide assessment of the comparative effects of chest physiotherapy and positive expiratory pressure mask in cystic fibrosis. Pediatr Pulmonol 1990;(Suppl 5):251
83. Costantini D, Brivio A, Brusa D, et al. PEP masks versus postural drainage in CF infants - a long-term comparative trial. Pediatr Pulmonol 2001;(Suppl 22):308
84. McIlwaine PM, Wong LT, Peacock D, Davidson AG. Long-term comparative trial of conventional postural drainage and percussion versus positive expiratory pressure physiotherapy in the treatment of cystic fibrosis. J Pediatr 1997;131:570-4
85. McIlwaine PM, Davidson AG. Comparison of positive expiratory pressure and autogenic drainage with conventional percussion and drainage therapy in the treatment of cystic fibrosis. In: Proceedings of the 17th European Cystic Fibrosis Conference, June 18-21, 1991, Copenhagen: S8.4
86. Arens R, Gozal D, Omlin KJ, et al. Comparison of high frequency chest compression and conventional chest physiotherapy in hospitalized patients with cystic fibrosis. Am J Respir Crit Care Med 1994;150:1154-7
87. Bauer ML, McDougal J, Schoumacher RA. Comparison of manual and mechanical chest percussion in hospitalized patients with cystic fibrosis. J Pediatr 1994;124:250-4
88. Davidson AGF, Wong LTK, Price GE, McIlwaine PM. Long-term comparative trial of conventional chest percussion and drainage physiotherapy versus autogenic drainage in cystic fibrosis. Pediatr Pulmonol 1992;14:235
89. Falk M, Kelstrup M, Andersen JB, et al. Improving the ketchup bottle method with positive expiratory pressure, PEP, in cystic fibrosis. Eur J Respir Dis 1984;65:423-32
90. Kofler AM, Carlesi A, Cutrera R, et al. BiPaP versus PEP as chest physiotherapy in patients with cystic fibrosis. Pediatr Pulmonol 1998; (Suppl 17): 344
91. McIlwaine PM, Wong LT, Peacock D, Davidson AG. Long-term comparative trial of positive expiratory pressure versus oscillating positive expiratory pressure (flutter) physiotherapy in the treatment of cystic fibrosis. J Pediatr 2001;138:845-50
92. Steen HJ, Redmond AO, O'Neill D, Beattie F. Evaluation of the PEP mask in cystic fibrosis. Acta Paediatr Scand 1991;80:51-6
93. Holland AE, Denby L, Ntoumenopoulos G, Naughton MT, Wilson JW. Non-invasive ventilation assists chest physiotherapy in adults with acute exacerbations of cystic fibrosis. Thorax 2003;58:880-4
94. Fauroux B, Boule M, Lofaso F, et al. Chest physiotherapy in cystic fibrosis: improved tolerance with nasal pressure support ventilation. Pediatrics 1999;103:1-9
95. Gaskin L, Corey M, Shin J, Reisman JJ, Thomas J, Tullis DE. Long term trial of conventional postural drainage and percussion vs. positive expiratory pressure. Pediatr Pulmonol 1998;(Suppl 17):345
96. Lannefors L, Wollmer P. Mucus clearance with three chest physiotherapy regimes in cystic fibrosis: a comparison between postural drainage, PEP and physical exercise. Eur Respir J 1992;5: 748-53
97. van Winden CM, Visser A, Hop W, Sterk PJ, Beckers S, de Jongste JC. Effects of flutter and PEP mask physiotherapy on symptoms and lung function in children with cystic fibrosis. Eur Respir J 1998;12: 143-7
98. Tyrrell JC, Hiller EJ, Martin J. Face mask physiotherapy in cystic fibrosis. Arch Dis Child 1986;61:598-611
99. Van Asperen PP, Jackson L, Hennessy P, Brown J. Comparison of a positive expiratory pressure (PEP) mask with postural drainage in patients with cystic fibrosis. Australian Paediat J 1987;23:283-4
100. Placidi G, Cornacchia M, Cappelletti LM, Mastella G, Assael BM, Braggion C. Short-term effects of positive airway pressure on sputum clearance by directed coughing: a cross-over, randomized study. Pediatric Pulmonol 2001;(Suppl 22):313-14
101. Hofmeyr JL, Webber BA, Hodson ME. Evaluation of positive expiratory pressure as an adjunct to chest physiotherapy in the treatment of cystic fibrosis. Thorax 1986;41:951-4
102. Lagerkvist A-LB, Sten GM Redfors SB, Lindblad AG, Hjalmarson O. Immediate changes in blood gas tensions during chest physiotherapy with positive expiratory pressure and oscillating expiratory pressure in patients with cystic fibrosis. Respir Care 2006;51:1154-61
103. Darbee JC, Ohtake PJ, Grant BJB, Cerny FJ. Physiological evidence for the efficiency of positive expiratory pressure as an airway-clearance technique in patients with cystic fibrosis. Physical Ther 2004;84:524-37
104. Newbold ME, Tullis E, Corey M, Ross B, Brooks D. The Flutter device versus the PEP mask in the treatment of adults with cystic fibrosis. Physiother Canada 2005;57:199-207
105. Homnick DN, Anderson K, Marks JH. Comparison of the flutter device to standard chest physiotherapy in hospitalized patients with cystic fibrosis: a pilot study. Chest 1998;114:993- 7
106. Gondor M, Nixon PA, Mutich R, Rebovich PJ, Orenstein DM. Comparison of flutter device and chest physical therapy in the treatment of cystic fibrosis pulmonary exacerbation. Pediatric Pulmonol 1999;28:255-60
107. Warwick WJ, Wielinski CL, Hansen LG. Comparison of expectorated sputum after manual chest physical therapy and high-frequency chest compression. Biomed Instrum Technol 2004;38:470-5
108. Darbee JC, Kanga JF, Ohtake PJ. Physiological evidence for high frequency chest wall oscillation and positive expiratory pressure breathing in hospitalized subjects with cystic fibrosis. Physical Ther 2005;85:1278-89
109. Kluft J, Beker L, Castagnino M, Gaiser J, Chaney H, Fink RJ. A comparison of bronchial drainage treatments in cystic fibrosis. Pediatr Pulmonol 1996; 22: 271-4
110. Majaesic CM, Montgomery M, Jones R, King M. Reduction in Sputum Viscosity using High Frequency Chest Compressions (HFCC) compared to Conventional Chest Physiotherapy (CCP). Pediatric Pulmonol 1996;Suppl 13:308.
111. Scherer TA, Barandun J, Martinez E, Wanner A, Rubin EM. Effect of high frequency oral airway and chest wall oscillation and conventional chest physical therapy on expectoration in patients with stable cystic fibrosis. Chest 1998;113:1019-1027
112. Phillips GE, Pike SE, Jaffe A, et al. Comparison of active cycle of breathing and high-frequency oscillation jacket in children with cystic fibrosis. Pediatr Pulmonol 2004;37:71-75
113. Homnick DN, White F, de Castro C. Comparison of effects of an intrapulmonary percussive ventilator to standard aerosol and chest physiotherapy in treatment of cystic fibrosis. Pediatric Pulmonol 1995; 20:50-55.
114. Marks JH, Hare KL, Saunders RA, Homnick DN. Pulmonary Function and Sputum Production in Patients with Cystic Fibrosis: A Pilot Study Comparing the PercussiveTech HF Device and Standard Chest Physiotherapy. Chest 2004;125:1507-1511.
115. Natale JE, Pfeifle J, Homnick DN. Comparison of intrapulmonary percussive ventilation and chest physiotherapy. A pilot study in patients with cystic fibrosis. Chest 1994;105:1789-1793
116. Newhouse PA, White F, Marks JH, Homnick DN. The intrapulmonary percussive ventilator and flutter device compared to standard chest physiotherapy in patients with cystic fibrosis. Clinical Pediatrics 1998;37:427- 432.
117. Kofler AM, Carlesi A, Cutrera R, Leone P, Lucidi V, Rosati S. BiPAP versus PEP as chest physiotherapy in patients with cystic fibrosis. Pediatr Pulmonol 1998;(Suppl 17):344
118. Gozal D. Nocturnal ventilatory support in patients with cystic fibrosis: comparison with supplemental oxygen. Eur Respir J 1997;10:1999- 2003
119. Cantin AM, Bacon M, Bertiaume Y. Mechanical airway clearance using the frequenter electro-acoustical transducer in cystic fibrosis. Clin Invest Med 2006;29:159-65
120. Jarad NA, Powell T, Smith EC, Cartwright P, Nedwell J. The efficacy, preference, and safety of a novel method of sputum clearance, hydro-acoustic therapy, on adult patients with cystic fibrosis. Thorax 2006;61 (Suppl 11):ii120
121. Milla CE, Hansen LG, Weber A, Warwick WJ. High-frequency chest compression: effect of the third generation compression waveform. Biomed Instrum Technol 2004;38:322-8
122. Milla CE, Hansen LG, Warwick WJ. Different frequencies should be prescribed for different high frequency chest compression machines. Biomed Instrum Technol 2006;40:319-24
123. Sohn K, WJ Warwick, Lee YW, Lee J, Holte JE. Investigation of non-uniform airflow signal oscillation during high frequency chest compression. Biomed Eng Online 2005 [http://www.biomedical-engineering-online.com/content/4/1/ 34]
124. Volsko TA, DiFiore JM, Chatburn RL. Performance comparison of two oscillating positive expiratory pressure devices: Acapella versus Flutter. Respir Care 203;48:124-30
125. McFadden ER, Linden DA. A reduction in maximum mid-expiratory flow rate. A spirographic manifestation of small airway disease. Am J Med 1972;52:725-37
126. Landau LI, Hill DJ, Phelan PD. Factors determining the shape of maximum expiratory flow-volume curves in childhood asthma. Aust N Z J Med 1973;3:557-64
127. Woolcock AJ. Effects of drugs on small airways. Am J Respir Crit Care Med 1998;157 (Suppl 5): S203-7
128. 2 plateau. Respir Physiol 1981;44:325-37
129. Gustafsson PM, Aurora P, Linblad A. Evaluation of ventilation maldistribution as an early indicator of lung disease in children with cystic fibrosis. Eur Respir J 2003;22:972-9
130. Aurora P, Gustafsson PM, Bush A, et al. Multiple breath inert gas washout as a measure of ventilation distribution in children with cystic fibrosis. Thorax 2004;59:1068-73
131. Smith HJ, Reinhold P, Goldman MD. Forced oscillation technique and impulse oscillometry. Eur Respir Mon 2005;31:72-105
132. Braverman JM. Treatment Adherence: Airway Clearance Therapy in Cystic Fibrosis [www.thevest.com/research/whitepapers/855ABtrtmntAdherence.pdf]